Focusing in on COPD

SNG001 – currently in Phase II clinical trial

FIBROSIS

LOXL2 programme (being progressed by Pharmaxis)
– Phase I clinical trials complete

About us

Synairgen is a drug discovery and development company founded by University of Southampton Professors Stephen Holgate, Donna Davies and Ratko Djukanovic.

BIOBANK
PLATFORM

Latest
news

 

14th March 2019

Positive DSMC Review of Phase II Study for SNG001